INTRA-ARTICULAR MM-II, A NOVEL SUSPENSION OF LARGE EMPTY MULTILAMELLAR LIPOSOMES, IN PAINFUL KNEE OSTEOARTHRITIS: A 26 WEEK PHASE 2B RANDOMIZED TRIAL

被引：0
|
作者：
Conaghan, P. G. [1 ]
Rovsing, H. [2 ]
Lau, E. [3 ]
Boll, S. L. [4 ]
Brahmachari, B. [5 ]
Chou, R. C. [5 ]
Joshi, T. [5 ]
Wechsler, R. [6 ]
Yao, S. L. [5 ]
Weiner, S. [5 ]
Bihlet, A. R. [7 ]
Schnitzer, T. [8 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Sanos Clin, Gandrup, Denmark
[3] Hong Kong Ctr Clin Res, Hong Kong, Peoples R China
[4] Sanos Clin, Vejle, Denmark
[5] Sun Pharmaceut Inc, Princeton, NJ USA
[6] Moebius Med Ltd, Tel Aviv, Israel
[7] NBCD, Soborg, Denmark
[8] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Osteoarthritis; Clinical Trials;
D O I：
10.1136/annrheumdis-2023-eular.5397
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0106
引用
收藏
页码：266 / 267
页数：2
相关论文
共 48 条
  • [1] Efficacy and Safety of a Single Intra-Articular Injection of MM-II, a Novel Suspension of Large, Empty, Multilamellar Liposomes, in People with Painful Knee OA: Results of a 26-Week, Phase 2b, Placebo-Controlled, Double-Blind, Randomized Trial
    Thomas, Schnitzer
    Rovsing, Helene
    Lau, Edith
    Boll, Sidsel
    Brahmachari, Ballari
    Chou, Richard
    Joshi, Tarini
    Wechsler, Roni
    Yao, Siu-Long
    Weiner, Sveta
    Bihlet, Asger
    Conaghan, Philip
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2342 - 2344
  • [2] SAFETY AND EFFICACY OF MM-II, AN INTRA-ARTICULAR INJECTION OF LIPOSOMES, IN MODERATE KNEE OSTEOARTHRITIS. PROSPECTIVE RANDOMIZED DOUBLE-BLINDED STUDY
    Kandel, L.
    Dolev, Y.
    Rivkind, G.
    Liebergall, M.
    Mattan, Y.
    Barenholz, Y.
    Shimonov, R.
    Chevalier, X.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S193 - S193
  • [3] A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Lattermann, C.
    Skrepnik, N.
    Swearingen, C. J.
    Simsek, I.
    Ghandehari, H.
    DiFrancesco, A.
    Gibbs, J.
    Tambiah, J. R. S.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 (05) : 654 - 666
  • [4] RESULTS FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Lattermann, C.
    Skrepnik, N.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S183 - S184
  • [5] Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial
    Jeyanesh R. S. Tambiah
    Sarah Kennedy
    Christopher J. Swearingen
    Ismail Simsek
    Yusuf Yazici
    Jack Farr
    Philip G. Conaghan
    Rheumatology and Therapy, 2021, 8 : 973 - 985
  • [6] Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial
    Tambiah, Jeyanesh R. S.
    Kennedy, Sarah
    Swearingen, Christopher J.
    Simsek, Ismail
    Yazici, Yusuf
    Farr, Jack
    Conaghan, Philip G.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 973 - 985
  • [7] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    McAlindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Latterman, Christian
    Skrepnik, Nebojsa
    Swearingen, Chris
    DiFrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    Grifman, Mirta
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S12 - S12
  • [8] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Latterman, C.
    Skrepnik, N.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S503 - S503
  • [9] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    Mcalindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Lattermann, Christian
    Skrepnik, Nebojsa
    Swearingen, Christopher
    Difrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 519 - 519
  • [10] USING PAIN TOLERABILITY THRESHOLDS TO CHARACTERIZE CLINICALLY MEANINGFUL TREATMENT OUTCOMES IN KNEE OSTEOARTHRITIS: POST HOC ANALYSIS OF A PHASE 2B TRIAL OF INTRA-ARTICULAR LORECIVIVINT
    Markman, J. D.
    Bennett, H.
    Kennedy, S.
    Tambiah, J. R.
    Swearingen, C. J.
    Gewandter, J. S.
    OSTEOARTHRITIS AND CARTILAGE, 2022, 30 : S378 - S379
12345